Suzanne M. Vogt
About Suzanne M. Vogt
Suzanne M. Vogt is a Manager- CMC Project Manager at Bristol Myers Squibb in the United States with extensive experience in clinical research and project management.
Company
Suzanne M. Vogt is currently employed at Bristol Myers Squibb. She serves as the Manager - CMC Project Manager in the United States. Bristol Myers Squibb is a global biopharmaceutical company engaged in the discovery, development, and delivery of innovative medicines to treat serious diseases.
Title
Suzanne M. Vogt holds the position of Manager - CMC Project Manager. As part of her role, she is involved in the management of early-stage and late-stage programs for the manufacturing of raw materials such as viral vectors and plasmids used in drug products.
Education and Expertise
Suzanne M. Vogt holds a Master of Science degree in Clinical Cardiopulmonary Physiology from Northeastern University, achieved from 2006 to 2008. She also holds a Bachelor of Science degree in Kinesiology and Exercise Science from Washington State University, achieved from 2002 to 2006. Her academic background lays a strong foundation in both research and practical applications within the healthcare and clinical research fields.
Professional Background
Suzanne M. Vogt has a diverse professional background spanning over several roles and institutions. She has held positions such as Clinical Affairs Project Specialist at Cardiac Dimensions from 2018 to 2020, Clinical Research Supervisor at Benaroya Research Institute from 2011 to 2017, and Clinical Research Project Manager at Brigham and Women's Hospital from 2008 to 2009. Additionally, she has experience in project management, clinical research supervision, and personal training from various organizations including University of Washington IMA, Skyline at FirstHill, and Boston Sports Club.
Achievements in Project Management
In her current role, Suzanne M. Vogt has led multiple cross-functional and matrix teams to ensure that regulatory, quality, manufacturing, governance, and supply targets are met for clinical trials. She has managed early-stage and late-stage programs for the manufacturing of crucial raw materials and has supported the integration of these materials into active supply chains for clinical trials. She has also handled both non-GMP and GMP manufacturing technical transfer projects, developing project timelines and operations tools to facilitate effective project management.